204 related articles for article (PubMed ID: 9275109)
1. Risks of transplanting kidneys from hepatitis B surface antigen-negative, hepatitis B core antibody-positive donors.
Satterthwaite R; Ozgu I; Shidban H; Aswad S; Sunga V; Zapanta R; Asai P; Bogaard T; Khetan U; Mendez RG; Mendez R
Transplantation; 1997 Aug; 64(3):432-5. PubMed ID: 9275109
[TBL] [Abstract][Full Text] [Related]
2. Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease.
Madayag RM; Johnson LB; Bartlett ST; Schweitzer EJ; Constantine NT; McCarter RJ; Kuo PC; Keay S; Oldach DW
Transplantation; 1997 Dec; 64(12):1781-6. PubMed ID: 9422420
[TBL] [Abstract][Full Text] [Related]
3. Pre-transplant donor HBV DNA+ and male recipient are independent risk factors for treatment failure in HBsAg+ donors to HBsAg- kidney transplant recipients.
Wang XD; Feng SJ; Liu JP; Song TR; Huang ZL; Fan Y; Shi YY; Chen LY; Lv YH; Xu ZL; Li XH; Wang L; Lin T
BMC Infect Dis; 2021 Jan; 21(1):41. PubMed ID: 33422017
[TBL] [Abstract][Full Text] [Related]
4. Transplanting kidneys from donors with prior hepatitis B infection: one response to the organ shortage.
Fabrizio F; Bunnapradist S; Martin P
J Nephrol; 2002; 15(6):605-13. PubMed ID: 12495272
[TBL] [Abstract][Full Text] [Related]
5. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
[TBL] [Abstract][Full Text] [Related]
6. Kidney Transplantation From Hepatitis B Surface Antigen (HBsAg)-Positive Living Donors to HBsAg-Negative Recipients: Clinical Outcomes at a High-Volume Center in China.
Wang XD; Liu JP; Song TR; Huang ZL; Fan Y; Shi YY; Chen LY; Lv YH; Xu ZL; Li XH; Wang L; Lin T
Clin Infect Dis; 2021 Mar; 72(6):1016-1023. PubMed ID: 32100025
[TBL] [Abstract][Full Text] [Related]
7. Expanding the donor pool: Kidney transplantation from serum HBV DNA or HBeAg-positive donors to HBsAg-negative recipients.
Yin S; Wu L; Zhang F; Huang X; Wu J; Wang X; Lin T
Liver Int; 2023 Nov; 43(11):2415-2424. PubMed ID: 37592870
[TBL] [Abstract][Full Text] [Related]
8. Use of hepatitis B core antibody-positive donor kidneys in hepatitis B surface antibody-positive and -negative recipients.
Veroux M; Puliatti C; Gagliano M; Cappello D; Macarone M; Vizcarra D; Spataro M; Di Mare M; Ginevra N; Veroux P
Transplant Proc; 2005; 37(6):2574-5. PubMed ID: 16182748
[TBL] [Abstract][Full Text] [Related]
9. Renal grafts from anti-hepatitis B core-positive donors: a quantitative review of the literature.
Mahboobi N; Tabatabaei SV; Blum HE; Alavian SM
Transpl Infect Dis; 2012 Oct; 14(5):445-51. PubMed ID: 22970743
[TBL] [Abstract][Full Text] [Related]
10. Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China.
Lei M; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG
World J Gastroenterol; 2018 Dec; 24(48):5525-5536. PubMed ID: 30622380
[TBL] [Abstract][Full Text] [Related]
11. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors.
Wachs ME; Amend WJ; Ascher NL; Bretan PN; Emond J; Lake JR; Melzer JS; Roberts JP; Tomlanovich SJ; Vincenti F
Transplantation; 1995 Jan; 59(2):230-4. PubMed ID: 7839446
[TBL] [Abstract][Full Text] [Related]
12. Safety of using hepatitis B virus core antibody or surface antigen-positive donors in kidney or pancreas transplantation.
Akalin E; Ames S; Sehgal V; Murphy B; Bromberg JS
Clin Transplant; 2005 Jun; 19(3):364-6. PubMed ID: 15877799
[TBL] [Abstract][Full Text] [Related]
13. Kidney transplantation from hepatitis B virus core antibody-positive donors: prophylaxis with hepatitis B immunoglobulin.
Veroux M; Corona D; Ekser B; Giaquinta A; Tallarita T; De Martino C; Gentile F; Virgilio C; Gagliano M; Fiamingo P; Veroux P
Transplant Proc; 2011 May; 43(4):967-70. PubMed ID: 21620027
[TBL] [Abstract][Full Text] [Related]
14. The effect of HBsAg-positivity of kidney donors on long-term patient and graft outcome.
Berber I; Aydin C; Yigit B; Turkmen F; Titiz IM; Altaca G
Transplant Proc; 2005 Dec; 37(10):4173-5. PubMed ID: 16387070
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study.
Angelico M; Nardi A; Marianelli T; Caccamo L; Romagnoli R; Tisone G; Pinna AD; Avolio AW; Fagiuoli S; Burra P; Strazzabosco M; Costa AN;
J Hepatol; 2013 Apr; 58(4):715-23. PubMed ID: 23201239
[TBL] [Abstract][Full Text] [Related]
16. Failure of reactivation of hepatitis B after liver transplantation in hepatitis B surface antigen-negative, core antibody-positive recipients.
Maguire D; Heaton ND; Smith HM
Transplantation; 2002 Feb; 73(3):481-2. PubMed ID: 11884950
[TBL] [Abstract][Full Text] [Related]
17. Lamivudine monoprophylaxis for de novo HBV infection in HBsAg-negative recipients with HBcAb-positive liver grafts.
Vizzini G; Gruttadauria S; Volpes R; D'Antoni A; Pietrosi G; Filì D; Petridis I; Pagano D; Tuzzolino F; Santonocito MM; Gridelli B
Clin Transplant; 2011; 25(1):E77-81. PubMed ID: 21039887
[TBL] [Abstract][Full Text] [Related]
18. Impact of hepatitis B core antibody status on outcomes of cadaveric renal transplantation: analysis of United network of organ sharing database between 1994 and 1999.
Fong TL; Bunnapradist S; Jordan SC; Cho YW
Transplantation; 2002 Jan; 73(1):85-9. PubMed ID: 11792984
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B core antibody positive donors as a safe and effective therapeutic option to increase available organs for lung transplantation.
Hartwig MG; Patel V; Palmer SM; Cantu E; Appel JZ; Messier RH; Davis RD
Transplantation; 2005 Aug; 80(3):320-5. PubMed ID: 16082326
[TBL] [Abstract][Full Text] [Related]
20. Retrospective evaluation of the risk of hepatitis B virus reactivation after transplantation.
Duhart BT; Honaker MR; Shokouh-Amiri MH; Riely CA; Vera SR; Taylor SL; Al-jedai AH; Gaber AO
Transpl Infect Dis; 2003 Sep; 5(3):126-31. PubMed ID: 14617300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
